Cellectar Biosciences Nets Patent
The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent (No. P150207US03) that covers a method of use for CLR 131 in multiple myeloma, the company announced today….
Category Archives: Biotech
Exact Sciences Names Cologuard President
Exact Sciences named Mark Stenhouse as president of Cologuard, its noninvasive stool DNA-based test for early detection of colon cancer, the company announced recently. “More than 85 million people are…
Cellectar Receives Orphan Drug Designation
Cellectar Biosciences has been granted orphan drug designation for its therapeutic, CLR 131, by the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development for the treatment of neuroblastoma,…
Exact Sciences Adds Co-Chief Medical Officer
Exact Sciences named Paul J. Limburg, M.D., M.P.H., as its co-chief medical officer, the company announced today. “Dr. Limburg’s valuable mix of cancer prevention experience in both the clinical and…
One Million Screened Using Cologuard
Exact Sciences’ Cologuard has been used in more than one million screenings for colorectal cancer, the company announced today. “Approximately half of Cologuard users haven’t been screened before, and we’re…
Lucigen Acquired by London Company
Lucigen announced today that it has been acquired by LGC, an international, privately owned company in the extended life sciences sector that seeks to strengthen its reagents offering in the genomics…
SHINE’s First Building Complete
SHINE Medical Technologies has completed construction and taken occupancy of Building One, the first building of its medical isotope production campus, the company announced today. “Building One’s name was chosen…
Takeda to Commercialize CDI’s Cells
Fujifilm, the company that acquired Cellular Dynamics International (CDI), is partnering with Takeda Pharmaceutical, the company announced recently. According to a release, Takeda will collaboratively and globally commercialize regenerative medicine products using…
Cellectar Earns Allowance for Patent
The U.S. Patent and Trademark Office awarded Cellectar Biosciences a notice of allowance for a patent covering the use of CLR 131 in multiple myeloma (MM), the company announced today. “This patent…
AmebaGone Provides Alternative to Antibiotics
When it comes to the best and healthiest organic plants, it’s difficult to avoid disease and harmful bacteria taking over the crops. AmebaGone provides a solution. This Madison-based startup has…
